Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong · Delayed Price · Currency is HKD 34.16
+0.96 (2.89%)
Sep 11, 2026, 3:58 PM HKT
HKG:1501 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,200 | 1,065 | 851.95 | 752.84 | 585.88 | 464.68 | |
Revenue Growth | 30.38% | 25.06% | 13.17% | 28.50% | 26.08% | 29.64% |
Cost of Revenue | 469.95 | 428.69 | 314.29 | 314.77 | 253.4 | 188.93 |
Gross Profit | 730.51 | 636.79 | 537.66 | 438.07 | 332.49 | 275.75 |
Selling, General & Admin | 321.13 | 266.05 | 200.23 | 166.82 | 120.68 | 79.07 |
Research & Development | 152.52 | 150.06 | 149.13 | 125.85 | 99.63 | 89.96 |
Other Operating Expenses | -55.82 | -37.4 | -23.1 | -17 | -18.1 | -38.49 |
Operating Expenses | 418.95 | 378.49 | 325.64 | 276.08 | 203.14 | 131.11 |
Operating Income | 311.55 | 258.29 | 212.02 | 161.99 | 129.34 | 144.64 |
Interest Expense | -18.48 | -12.54 | -2.43 | -3.19 | -0.82 | -0.63 |
Interest & Investment Income | 24.93 | 11.99 | 9.11 | 11.83 | 13.41 | 14.53 |
Earnings From Equity Investments | - | -0.59 | -0.4 | - | - | - |
Currency Exchange Gain (Loss) | -39.16 | -5.98 | 3.11 | 2.42 | 2.54 | -2.84 |
EBT Excluding Unusual Items | 278.85 | 251.17 | 221.41 | 173.05 | 144.47 | 155.69 |
Gain (Loss) on Sale of Investments | 7.15 | 7.15 | -8.03 | 2.08 | - | - |
Asset Writedown | -3.7 | - | - | - | - | - |
Pretax Income | 282.3 | 258.32 | 213.38 | 175.13 | 144.47 | 155.69 |
Income Tax Expense | 26.39 | 25.65 | 23.34 | 21.9 | 10.64 | 15.25 |
Earnings From Continuing Operations | 255.91 | 232.67 | 190.05 | 153.23 | 133.83 | 140.45 |
Minority Interest in Earnings | -25.33 | -13.89 | 1.87 | 3.23 | -2.12 | 2.52 |
Net Income | 230.58 | 218.79 | 191.91 | 156.46 | 131.71 | 142.96 |
Preferred Dividends & Other Adjustments | 12.31 | 12.56 | 11 | 4.58 | 1.57 | - |
Net Income to Common | 218.28 | 206.23 | 180.92 | 151.88 | 130.15 | 142.96 |
Net Income Growth | 21.94% | 13.99% | 19.12% | 16.70% | -8.96% | 17.80% |
Shares Outstanding (Basic) | 179 | 164 | 165 | 166 | 166 | 166 |
Shares Outstanding (Diluted) | 188 | 172 | 171 | 171 | 169 | 167 |
Shares Change | 9.77% | 0.92% | -0.11% | 1.10% | 1.32% | 0.48% |
EPS (Basic) | 1.22 | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 |
EPS (Diluted) | 1.22 | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 |
EPS Growth | 11.80% | 14.17% | 20.10% | 17.49% | -9.38% | 17.81% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 283.63 | 99.8 | 9.31 | -62.75 | -205.07 |
Free Cash Flow Per Share | - | 1.65 | 0.58 | 0.05 | -0.37 | -1.23 |
Dividend Per Share | - | 0.230 | - | 0.270 | 0.240 | 0.260 |
Dividend Growth | - | - | - | 12.50% | -7.69% | -8.77% |
Gross Margin | 60.85% | 59.77% | 63.11% | 58.19% | 56.75% | 59.34% |
Operating Margin | 25.95% | 24.24% | 24.89% | 21.52% | 22.08% | 31.13% |
Profit Margin | 18.18% | 19.36% | 21.24% | 20.18% | 22.21% | 30.77% |
Free Cash Flow Margin | - | 26.62% | 11.71% | 1.24% | -10.71% | -44.13% |
EBITDA | 411.7 | 353.06 | 286.75 | 204.78 | 159.99 | 168.81 |
EBITDA Margin | 34.30% | 33.14% | 33.66% | 27.20% | 27.31% | 36.33% |
D&A For EBITDA | 100.15 | 94.77 | 74.73 | 42.79 | 30.65 | 24.17 |
EBIT | 311.55 | 258.29 | 212.02 | 161.99 | 129.34 | 144.64 |
EBIT Margin | 25.95% | 24.24% | 24.89% | 21.52% | 22.08% | 31.13% |
Effective Tax Rate | 9.35% | 9.93% | 10.94% | 12.50% | 7.36% | 9.79% |